<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="publisher-id">abd</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26560224</article-id>
      <article-id pub-id-type="pmc">4631244</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20153390</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Mucosal-dominant pemphigus vulgaris in a captopril-taking woman with
angioedema<xref ref-type="fn" rid="fn01">*</xref></article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Gornowicz-Porowska</surname>
            <given-names>Justyna</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Dmochowski</surname>
            <given-names>Marian</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pietkiewicz</surname>
            <given-names>Pawel</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bowszyc-Dmochowska</surname>
            <given-names>Monika</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <aff id="aff01"><label>1</label>Poznan University of Medical Sciences &#x2013; Poznan,
Poland.</aff>
      </contrib-group>
      <author-notes>
        <corresp id="c01">MAILING ADDRESS: Justyna Gornowicz-Porowska, 49 Przybyszewski Street,
60-355 Poznan, Poland. E-mail:
<email>justynagornowicz1@poczta.onet.pl</email></corresp>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>Sep-Oct</season>
        <year>2015</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Sep-Oct</season>
        <year>2015</year>
      </pub-date>
      <volume>90</volume>
      <issue>5</issue>
      <fpage>748</fpage>
      <lpage>751</lpage>
      <history>
        <date date-type="received">
          <day>21</day>
          <month>1</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>17</day>
          <month>3</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2015 by Anais Brasileiros de Dermatologia</copyright-statement>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>We describe a 39-year-old woman with an apparent captopril-induced, contact
mucosal-dominant pemphigus vulgaris and angioedema, who took captopril during a bout
of arterial hypertension. This exposure suggests that captopril and pathophysiology
of angioedema stimulated the development of pemphigus vulgaris, which was diagnosed
using the novel, indirect immunofluorescence BIOCHIP mosaic, with the modification to
detect serum IgG4 autoantibodies. We discuss the patient, who experienced a chain of
events leading to the active stage of pemphigus vulgaris, and review concepts of
pemphigus vulgaris inducible by drugs and pathological immunity.</p>
      </abstract>
      <kwd-group>
        <kwd>Angioedema</kwd>
        <kwd>Captopril</kwd>
        <kwd>Pemphigus</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Autoimmune blistering dermatoses (ABDs), especially pemphigus vulgaris (PV) and mucous
membrane pemphigoid, are uncommon causes of chronic oral lesions. Early diagnosis and
prompt/correct treatment are essential to prevent serious involvement of other sites and
even death. Checks on systemic diseases and previous exposition to drugs are advisable
in patients with ABDs.</p>
      <p>Chronic PV lesions may develop in patients presenting with arterial hypertension (AH),
treated with angiotensin-converting-enzyme inhibitors (ACEI), but they have not been
described in relation to angioedema.<sup><xref rid="r01" ref-type="bibr">1</xref></sup></p>
      <p>Here, we describe a case of contact mucosal-dominant PV, probably induced by captopril
throughout the course of angioedema and its management.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>We received a 39-year-old woman with a 4-month history of oral lesions, previously
diagnosed as having angioedema without urticaria (at the age of 9) and AH (<xref ref-type="fig" rid="f01">Figure 1 A</xref>,<xref ref-type="fig" rid="f01">B</xref>).</p>
      <fig id="f01" orientation="portrait" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Mucosal erosions on the soft palate (A). Blood-filled blister on erythematous base
on the side of the tongue (B). Indirect immunofluorescence (IIF) on monkey
esophagus: Serum IgG pemphigus antibodies (C). Direct immunofluorescence of
perilesional oral mucous membrane: IgG4 pemphigus deposits (D). IIF mosaic for
autoimmune blistering dermatoses: IgG (E) and IgG4 (F) autoantibodies to
extracellular and transmembrane domains of DSG3 expressed in transfected HEK293 E
F cells</p>
        </caption>
        <graphic xlink:href="abd-90-05-0748-g01"/>
      </fig>
      <p>She took captopril <italic>pro re nata</italic> ("as required") sublingually for AH
episodes and showed no signs of involvement of cutaneous or other mucosal surfaces.
Investigations revealed slight blood eosinophilia (8%). Indirect immunofluorescence
(IIF) on monkey esophagus revealed IgG (<xref ref-type="fig" rid="f01">Fig. 1C</xref>)
and IgG4 pemphigus-type antibodies (titre: &gt;1/80 and 1/80, respectively). Direct
immunofluorescence of oral mucosa showed IgG4 (+) (<xref ref-type="fig" rid="f01">Fig.
1D</xref>) and C3 (++), but not IgA, IgM, IgG or IgG1, pemphigus deposits.
Histopathology H+E staining did not allow for unequivocal evaluation due to a lack of
oral epithelium in the specimen sent to the laboratory. Anti-desmoglein 3 (DSG3) IgG and
IgG4 (<xref ref-type="fig" rid="f01">Fig. 1E</xref>,<xref ref-type="fig" rid="f01">F</xref>) were detected in the serum using IIF on 6-substrate mosaic (monkey
esophagus; primate salt-split skin; dots of tetrameric BP180-NC16A; DSG1/DSG3 -
extracellular and transmembrane domains; BP230 C-terminal domain expressed in HEK293
cells).<sup><xref rid="r02" ref-type="bibr">2</xref></sup> The ELISA demonstrated
elevated serum IgG anti-DSG3, but not anti-DSG1, autoantibodies (&gt;200 RU/ml and 1.514
RU/ml, respectively; manufacturer cut-off 20 RU/ml).</p>
      <p>IIF and ELISA kits were produced by the German company Euroimmun.</p>
      <p>Based on clinical, immunopathological and biochemical/molecular data, a diagnosis of an
apparently captopril-induced, contact mucosal-dominant PV was established.</p>
      <p>At the hospital, the patient was advised to refrain from taking pemphigus-triggering
drugs and to take the following orally: doxycycline 2x100mg/day, niacinamide 1200mg/day
and cetirizine dihydrochloride 2x10mg/day. She also received cyclosporine solution as a
mouthwash (twice a day). The oral lesions initially became less burdensome.</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>The etiology of PV is multifactorial, often resulting from environmental triggers acting
on a proper genetic/immunological predisposition.</p>
      <p>Commonly, these triggers include drugs, physical/infectious agents, cancers and even
pesticides. Thence, 5 subtypes of drug-induced pemphigus (DIP) may be
postulated.<sup><xref rid="r01" ref-type="bibr">1</xref></sup> Our experience
suggests that in suspected DIP cases, <italic>ex vivo</italic> tests with triggering
drugs should be performed instead of oral provocation tests to eliminate the unknown
organism's influences. The use of provocative tests is also unwise due to the grave
nature of pemphigus.</p>
      <p>There are data indicating an association between ACEI (e.g. captopril) and
pemphigus.<sup><xref rid="r01" ref-type="bibr">1</xref></sup> However, the
pathogenesis of captopril-induced pemphigus is unknown. Perhaps the most relevant
mechanism to the reported case herein is contact pemphigus. Brenner <italic>et
al.</italic><sup><xref rid="r03" ref-type="bibr">3</xref></sup> used the
sensitization pathophysiology of contact dermatitis to describe the sequence of events
in contact pemphigus (induction phase, elicitation phase, phenotypic manifestation).
Thus, chronic low-level captopril exposure, in conjunction with the angioedema
immunological background, could initiate in our patient the production of anti-DSGs
autoantibodies. Interestingly, the patient also had lesions on the soft palate that may
have been caused by: (i) indirect spreading of the drug influences to more distant
sites, (ii) absorption of the drug.</p>
      <p>Sebaratnam <italic>et al.</italic><sup><xref rid="r04" ref-type="bibr">4</xref></sup>
reported a pemphigus foliaceus relapse induced by topical imiquimod therapy for basal
cell carcinoma (BCC). As it is postulated that DSG3 is involved in both pemphigus and
BCC pathogenesis, we cannot exclude the possibility of BCC as a contact pemphigus,
co-triggering factor.<sup><xref rid="r05" ref-type="bibr">5</xref></sup></p>
      <p>Underscoring the importance of the Th2-dependent IgG4 subtype in the active stages of
ABDs, we modified the commercial IIF mosaic to detect IgG4 autoantibodies.<sup><xref rid="r02" ref-type="bibr">2</xref>,<xref rid="r06" ref-type="bibr">6</xref></sup>
Hence, we demonstrated the presence of anti-DSG3 IgG4 isotype in the serum, suggesting
the active stage of PV. We use stably transfected HEK293 cells, which probably reveal no
physiological expression of desmosomal cadherins; however, the interpretation of IF
images with transfectants is occasionally too challenging for routine laboratory
work.</p>
      <p>The history of angioedema since childhood perhaps suggested a hereditary form resulting
from deficient production/function of C1 inhibitor.<sup><xref rid="r07" ref-type="bibr">7</xref></sup> Therefore, the patient was also advised to undergo diagnostics for
hereditary angioedema. Thus, proper diagnosis of angioedema revealed the initial factor
in pemphigus development. Furthermore, the complement and kinin pathways are recognized
as essential in angioedema onset/progression.<sup><xref rid="r07" ref-type="bibr">7</xref></sup> Interestingly, they are also important in acantholysis and blister
formation during pemphigus development (increased kinin formation in plasma of pemphigus
patients).<sup><xref rid="r08" ref-type="bibr">8</xref></sup> Hence, the linking
factors of angioedema and pemphigus may involve: (i) proteolytic enzymes, (ii) the
complement and kinin pathways. Additionally, successful administration of rituximab, the
useful monoclonal antibody for treating ABDs, in C1 inhibitor deficiency, suggests
overlying immune pathways in these disorders.<sup><xref rid="r09" ref-type="bibr">9</xref>,<xref rid="r10" ref-type="bibr">10</xref></sup></p>
      <p>Angioedema may be induced/worsen with ACEI acting on the ACE-modulated, entangled
kallikrein-kinin system, resulting in increased bradykinin<sup><xref rid="r07" ref-type="bibr">7</xref></sup>. Thus, captopril probably linked the angioedema and
pemphigus pathophysiologic processes in this particular case. Still, the associations
suggested here might be purely fortuitous (based on a single case), especially as there
was a 30-year interval between the occurrence of angioedema and clinical manifestation
of PV.</p>
      <p>The demonstration of IgG4 pemphigus mucosal deposits and serum IgG4 autoantibodies
<bold>to</bold> DSG3 E+TM expressed in HEK293 cells indicates that the patient,
following the repetitive chain of events - angioedema episodes treated intravenously
with <italic>ad hoc</italic> glucocorticosteroids, leading to AH episodes treated with
<italic>ad hoc</italic> sublingual captopril (even though this drug is
contraindicated for angioedema) - developed active pemphigus, but no pemphigus-like
reaction.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p>Conflict of Interest: None.</p>
      </fn>
      <fn fn-type="supported-by">
        <p>Financial Support: None.</p>
      </fn>
      <fn fn-type="other">
        <p><bold>How to cite this article:</bold> Gornowicz-Porowska J, Dmochowski M,
Pietkiewicz P, Bowszyc-Dmochowska M. Mucosal-dominant pemphigus vulgaris in a
captopril-taking woman with angioedema. An Bras Dermatol. 2015;90(5):748-51.</p>
      </fn>
      <fn fn-type="other" id="fn01">
        <label>*</label>
        <p>Work performed at the Autoimmune Blistering Dermatoses Section and Cutaneous
Histopathology and Immunopathology Section, Department of Dermatology, Poznan
University of Medical Sciences &#x2013; Poznan, Poland.</p>
      </fn>
    </fn-group>
    <ack>
      <title>ACKNOWLEDGMENTS</title>
      <p>IIF mosaic was obtained from EUROIMMUN (Germany) within the framework of a multicenter
project: "<italic>A European prospective study on serum antibodies against target
antigens of bullous autoimmune diseases and genetic susceptibility."</italic></p>
    </ack>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pietkiewicz</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Gornowicz-Porowska</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bowszyc-Dmochowska</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Dmochowski</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>A retrospective study of antihypertensives in pemphigus: a still
unchartered odyssey particularly between thiols, amides and
phenols</article-title>
          <source>Arch Med Sci</source>
          <year>2015</year>
          <volume>11</volume>
          <issue>5</issue>
          <fpage>1021</fpage>
          <lpage>1027</lpage>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van Beek</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Rentzsch</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Probst</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Komorowski</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Kasperkiewicz</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fechner</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Serological diagnosis of autoimmune bullous skin diseases: prospective
comparison of the BIOCHIP mosaic-based indirect immunofluorescence technique with
the conventional multi-step single test strategy</article-title>
          <source>Orphanet J Rare Dis</source>
          <year>2012</year>
          <volume>7</volume>
          <fpage>49</fpage>
          <lpage>49</lpage>
          <pub-id pub-id-type="pmid">22876746</pub-id>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brenner</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wolf</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Ruocco</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Contact pemphigus: a subgroup of induced pemphigus</article-title>
          <source>Int J Dermatol</source>
          <year>1994</year>
          <volume>33</volume>
          <fpage>843</fpage>
          <lpage>845</lpage>
          <pub-id pub-id-type="pmid">7883405</pub-id>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sebaratnam</surname>
              <given-names>DF</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>LK</given-names>
            </name>
            <name>
              <surname>Rubin</surname>
              <given-names>AI</given-names>
            </name>
            <name>
              <surname>Tran</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Pas</surname>
              <given-names>HH</given-names>
            </name>
            <name>
              <surname>Marr</surname>
              <given-names>PJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Reversible relapse of pemphigus foliaceus triggered by topical
imiquimod suggests that Toll-like receptor 7 inhibitors may be useful treatments
for pemphigus</article-title>
          <source>Clin Exp Dermatol</source>
          <year>2011</year>
          <volume>36</volume>
          <fpage>91</fpage>
          <lpage>93</lpage>
          <pub-id pub-id-type="pmid">20819088</pub-id>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pietkiewicz</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Gornowicz-Porowska</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bowszyc-Dmochowska</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Jagielska</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Helak-Lapaj</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Kaczmarek</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Discordant expression of desmoglein 2 and 3 at mRNA and protein levels
in nodular and superficial basal cell carcinoma revealed by immunohistochemistry
and fluorescent in situ hybridization</article-title>
          <source>Clin Exp Dermatol</source>
          <year>2014</year>
          <volume>39</volume>
          <fpage>628</fpage>
          <lpage>635</lpage>
          <pub-id pub-id-type="pmid">24934917</pub-id>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gornowicz-Porowska</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Pietkiewicz</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Dmochowski</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bowszyc-Dmochowska</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Immunoglobulin G4 is prevailing over immunoglobulin G1 in autoimmunity
of pemphigus and bullous pemphigoid: analysis of tissue-bound antibodies in active
diseases</article-title>
          <source>Centr Eur J Immunol</source>
          <year>2013</year>
          <volume>38</volume>
          <fpage>80</fpage>
          <lpage>91</lpage>
        </element-citation>
      </ref>
      <ref id="r07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lock</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Gompels</surname>
              <given-names>MM</given-names>
            </name>
          </person-group>
          <article-title>C1-inhibitor deficiencies (hereditary angioedema): where are we with
therapies?</article-title>
          <source>Curr Allergy Asthma Rep</source>
          <year>2007</year>
          <volume>7</volume>
          <fpage>264</fpage>
          <lpage>269</lpage>
          <pub-id pub-id-type="pmid">17547847</pub-id>
        </element-citation>
      </ref>
      <ref id="r08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rosatelli</surname>
              <given-names>TB</given-names>
            </name>
            <name>
              <surname>Roselino</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Dellalibera-Joviliano</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Reis</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Donadi</surname>
              <given-names>EA</given-names>
            </name>
          </person-group>
          <article-title>Increased activity of plasma and tissue kallikreins, plasma kininase
II and salivary kallikrein in pemphigus foliaceus (fogo selvagem)</article-title>
          <source>Br J Dermatol</source>
          <year>2005</year>
          <volume>152</volume>
          <fpage>650</fpage>
          <lpage>657</lpage>
          <pub-id pub-id-type="pmid">15840094</pub-id>
        </element-citation>
      </ref>
      <ref id="r09">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dobrev</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Popova</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Vlashev</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Proteinase inhibitors and pemphigus vulgaris. An in vitro and in vivo
study</article-title>
          <source>Arch Dermatol Res</source>
          <year>1996</year>
          <volume>288</volume>
          <fpage>648</fpage>
          <lpage>655</lpage>
          <pub-id pub-id-type="pmid">8931866</pub-id>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>S&#xE1;nchez-Cano</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Callejas-Rubio</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Lara-Jim&#xE9;nez</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>L&#xF3;pez-Trascasa</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Circadi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ortego-Centeno</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Successful use of rituximab in acquired C1 inhibitor deficiency
secondary to Sj&#xF6;gren's syndrome</article-title>
          <source>Lupus</source>
          <year>2008</year>
          <volume>17</volume>
          <fpage>228</fpage>
          <lpage>229</lpage>
          <pub-id pub-id-type="pmid">18372365</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
